PubMed:25677303
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 46-53 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 46-53 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 339-346 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 339-346 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T5 | 743-750 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 743-750 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 46-53 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T3 | 339-346 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
| T5 | 743-750 | Glycan_Motif | denotes | heparin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G54161DR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00021MO |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 54-69 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| T2 | 151-166 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| T3 | 168-170 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
| T4 | 347-349 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
| T5 | 436-438 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
| T6 | 751-753 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
| T7 | 1753-1755 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | HS |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-87 | Sentence | denotes | A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides. |
| TextSentencer_T2 | 88-227 | Sentence | denotes | The rare N-unsubstituted glucosamine (GlcNH(3)(+)) residues in heparan sulfate (HS) have important biological and pathophysiological roles. |
| TextSentencer_T3 | 228-439 | Sentence | denotes | Because of their low natural abundance, the use of chemically generated, structurally defined, N-unsubstituted heparin/HS oligosaccharides can greatly contribute to the investigation of their natural role in HS. |
| TextSentencer_T4 | 440-625 | Sentence | denotes | However, the sequencing of mixtures of chemically generated oligosaccharides presents major challenges due to the difficulties in separating isomers and the available detection methods. |
| TextSentencer_T5 | 626-771 | Sentence | denotes | In this study, we developed and validated a simple and sensitive method for the sequence analysis of N-unsubstituted heparin/HS oligosaccharides. |
| TextSentencer_T6 | 772-966 | Sentence | denotes | This protocol involves pH 4 nitrous acid (HNO(2)) degradation, size-exclusion HPLC and ion-pair reversed-phase liquid chromatography-ion trap/time-of-flight mass spectrometry (IPRP-LC-ITTOF MS). |
| TextSentencer_T7 | 967-1277 | Sentence | denotes | We unexpectedly found that absorbance at 232 nm (normally used for specific detection of C4-C5 unsaturated oligosaccharides) was, in most cases, still sufficiently sensitive to also simultaneously detect saturated oligosaccharides during HPLC, thus simplifying the positional analysis of GlcNH(3)(+)) residues. |
| TextSentencer_T8 | 1278-1419 | Sentence | denotes | The IPRP-LC-ITTOF MS system can supply further structural information leading to full sequence determination of the original oligosaccharide. |
| TextSentencer_T9 | 1420-1649 | Sentence | denotes | This new methodology has been used to separate and sequence a variety of chemically generated, N-unsubstituted dp6 species containing between 1 and 3 GlcNH(3)(+)) residues per oligosaccharide in different positional combinations. |
| TextSentencer_T10 | 1650-1891 | Sentence | denotes | This strategy offers possibilities for the sequencing of natural N-unsubstituted oligosaccharides from HS and should also be applicable, with minor modification, for sequencing at N-sulfated residues using alternative pH 1.5 HNO(2) scission. |
| T1 | 0-87 | Sentence | denotes | A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides. |
| T2 | 88-227 | Sentence | denotes | The rare N-unsubstituted glucosamine (GlcNH(3)(+)) residues in heparan sulfate (HS) have important biological and pathophysiological roles. |
| T3 | 228-439 | Sentence | denotes | Because of their low natural abundance, the use of chemically generated, structurally defined, N-unsubstituted heparin/HS oligosaccharides can greatly contribute to the investigation of their natural role in HS. |
| T4 | 440-625 | Sentence | denotes | However, the sequencing of mixtures of chemically generated oligosaccharides presents major challenges due to the difficulties in separating isomers and the available detection methods. |
| T5 | 626-771 | Sentence | denotes | In this study, we developed and validated a simple and sensitive method for the sequence analysis of N-unsubstituted heparin/HS oligosaccharides. |
| T6 | 772-966 | Sentence | denotes | This protocol involves pH 4 nitrous acid (HNO(2)) degradation, size-exclusion HPLC and ion-pair reversed-phase liquid chromatography-ion trap/time-of-flight mass spectrometry (IPRP-LC-ITTOF MS). |
| T7 | 967-1277 | Sentence | denotes | We unexpectedly found that absorbance at 232 nm (normally used for specific detection of C4-C5 unsaturated oligosaccharides) was, in most cases, still sufficiently sensitive to also simultaneously detect saturated oligosaccharides during HPLC, thus simplifying the positional analysis of GlcNH(3)(+)) residues. |
| T8 | 1278-1419 | Sentence | denotes | The IPRP-LC-ITTOF MS system can supply further structural information leading to full sequence determination of the original oligosaccharide. |
| T9 | 1420-1649 | Sentence | denotes | This new methodology has been used to separate and sequence a variety of chemically generated, N-unsubstituted dp6 species containing between 1 and 3 GlcNH(3)(+)) residues per oligosaccharide in different positional combinations. |
| T10 | 1650-1891 | Sentence | denotes | This strategy offers possibilities for the sequencing of natural N-unsubstituted oligosaccharides from HS and should also be applicable, with minor modification, for sequencing at N-sulfated residues using alternative pH 1.5 HNO(2) scission. |
| T1 | 0-87 | Sentence | denotes | A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides. |
| T2 | 88-227 | Sentence | denotes | The rare N-unsubstituted glucosamine (GlcNH(3)(+)) residues in heparan sulfate (HS) have important biological and pathophysiological roles. |
| T3 | 228-439 | Sentence | denotes | Because of their low natural abundance, the use of chemically generated, structurally defined, N-unsubstituted heparin/HS oligosaccharides can greatly contribute to the investigation of their natural role in HS. |
| T4 | 440-625 | Sentence | denotes | However, the sequencing of mixtures of chemically generated oligosaccharides presents major challenges due to the difficulties in separating isomers and the available detection methods. |
| T5 | 626-771 | Sentence | denotes | In this study, we developed and validated a simple and sensitive method for the sequence analysis of N-unsubstituted heparin/HS oligosaccharides. |
| T6 | 772-966 | Sentence | denotes | This protocol involves pH 4 nitrous acid (HNO(2)) degradation, size-exclusion HPLC and ion-pair reversed-phase liquid chromatography-ion trap/time-of-flight mass spectrometry (IPRP-LC-ITTOF MS). |
| T7 | 967-1277 | Sentence | denotes | We unexpectedly found that absorbance at 232 nm (normally used for specific detection of C4-C5 unsaturated oligosaccharides) was, in most cases, still sufficiently sensitive to also simultaneously detect saturated oligosaccharides during HPLC, thus simplifying the positional analysis of GlcNH(3)(+)) residues. |
| T8 | 1278-1419 | Sentence | denotes | The IPRP-LC-ITTOF MS system can supply further structural information leading to full sequence determination of the original oligosaccharide. |
| T9 | 1420-1649 | Sentence | denotes | This new methodology has been used to separate and sequence a variety of chemically generated, N-unsubstituted dp6 species containing between 1 and 3 GlcNH(3)(+)) residues per oligosaccharide in different positional combinations. |
| T10 | 1650-1891 | Sentence | denotes | This strategy offers possibilities for the sequencing of natural N-unsubstituted oligosaccharides from HS and should also be applicable, with minor modification, for sequencing at N-sulfated residues using alternative pH 1.5 HNO(2) scission. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 46-53 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 46-53 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T3 | 339-346 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T4 | 339-346 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
| T5 | 743-750 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T6 | 743-750 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
GlycoBiology-GDGDB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 1012-1014 | http://acgg.asia/db/diseases/gdgdb?con_ui=CON00386 | denotes | nm |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 46-53 | FMAID:167420 | denotes | heparin |
| _T2 | 46-53 | FMAID:82839 | denotes | heparin |
| _T3 | 54-61 | FMAID:67110 | denotes | heparan |
| _T4 | 54-61 | FMAID:165191 | denotes | heparan |
| _T5 | 54-69 | FMAID:63023 | denotes | heparan sulfate |
| _T6 | 54-69 | FMAID:167405 | denotes | heparan sulfate |
| _T7 | 70-86 | FMAID:196731 | denotes | oligosaccharides |
| _T8 | 70-86 | FMAID:82742 | denotes | oligosaccharides |
| _T9 | 113-124 | FMAID:196792 | denotes | glucosamine |
| _T10 | 113-124 | FMAID:82797 | denotes | glucosamine |
| _T11 | 151-158 | FMAID:165191 | denotes | heparan |
| _T12 | 151-158 | FMAID:67110 | denotes | heparan |
| _T13 | 151-166 | FMAID:63023 | denotes | heparan sulfate |
| _T14 | 151-166 | FMAID:167405 | denotes | heparan sulfate |
| _T15 | 339-346 | FMAID:82839 | denotes | heparin |
| _T16 | 339-346 | FMAID:167420 | denotes | heparin |
| _T17 | 350-366 | FMAID:196731 | denotes | oligosaccharides |
| _T18 | 350-366 | FMAID:82742 | denotes | oligosaccharides |
| _T19 | 500-516 | FMAID:196731 | denotes | oligosaccharides |
| _T20 | 500-516 | FMAID:82742 | denotes | oligosaccharides |
| _T21 | 670-680 | FMAID:62083 | denotes | simple and |
| _T22 | 670-680 | FMAID:165655 | denotes | simple and |
| _T23 | 743-750 | FMAID:167420 | denotes | heparin |
| _T24 | 743-750 | FMAID:82839 | denotes | heparin |
| _T25 | 754-770 | FMAID:82742 | denotes | oligosaccharides |
| _T26 | 754-770 | FMAID:196731 | denotes | oligosaccharides |
| _T27 | 883-889 | FMAID:85815 | denotes | liquid |
| _T28 | 1056-1058 | FMAID:63497 | denotes | C4 |
| _T29 | 1056-1058 | FMAID:167722 | denotes | C4 |
| _T30 | 1059-1061 | FMAID:167723 | denotes | C5 |
| _T31 | 1059-1061 | FMAID:63498 | denotes | C5 |
| _T32 | 1074-1090 | FMAID:196731 | denotes | oligosaccharides |
| _T33 | 1074-1090 | FMAID:82742 | denotes | oligosaccharides |
| _T34 | 1181-1197 | FMAID:82742 | denotes | oligosaccharides |
| _T35 | 1181-1197 | FMAID:196731 | denotes | oligosaccharides |
| _T36 | 1403-1418 | FMAID:196731 | denotes | oligosaccharide |
| _T37 | 1403-1418 | FMAID:82742 | denotes | oligosaccharide |
| _T38 | 1596-1611 | FMAID:196731 | denotes | oligosaccharide |
| _T39 | 1596-1611 | FMAID:82742 | denotes | oligosaccharide |
| _T40 | 1731-1747 | FMAID:196731 | denotes | oligosaccharides |
| _T41 | 1731-1747 | FMAID:82742 | denotes | oligosaccharides |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 909-913 | http://www.uniprot.org/uniprot/Q9UFF0 | denotes | trap |
| T2 | 962-964 | http://www.uniprot.org/uniprot/Q99707 | denotes | MS |
| T3 | 1296-1298 | http://www.uniprot.org/uniprot/Q99707 | denotes | MS |
| T4 | 1059-1061 | http://www.uniprot.org/uniprot/P01031 | denotes | C5 |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 909-913 | http://www.uniprot.org/uniprot/Q05117 | denotes | trap |
| T2 | 909-913 | http://www.uniprot.org/uniprot/Q8K1H1 | denotes | trap |
| T3 | 962-964 | http://www.uniprot.org/uniprot/A6H5Y3 | denotes | MS |
| T4 | 1296-1298 | http://www.uniprot.org/uniprot/A6H5Y3 | denotes | MS |
| T5 | 1056-1058 | http://www.uniprot.org/uniprot/Q62353 | denotes | C4 |
| T6 | 1059-1061 | http://www.uniprot.org/uniprot/P06684 | denotes | C5 |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 62-69 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T2 | 159-166 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T3 | 1832-1840 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfated |
| T4 | 644-653 | http://purl.obolibrary.org/obo/GO_0032502 | denotes | developed |
| T5 | 681-690 | http://purl.obolibrary.org/obo/GO_0046960 | denotes | sensitive |
| T6 | 1131-1140 | http://purl.obolibrary.org/obo/GO_0046960 | denotes | sensitive |
| T7 | 822-833 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
| T8 | 922-928 | http://purl.obolibrary.org/obo/GO_0060361 | denotes | flight |
EDAM-topics
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 6-16 | http://edamontology.org/topic_3168 | denotes | sequencing |
| T2 | 6-16 | http://edamontology.org/topic_0080 | denotes | sequencing |
| T3 | 279-313 | http://edamontology.org/topic_0154 | denotes | chemically generated, structurally |
| T4 | 290-313 | http://edamontology.org/topic_0114 | denotes | generated, structurally |
| T5 | 453-463 | http://edamontology.org/topic_3168 | denotes | sequencing |
| T6 | 453-463 | http://edamontology.org/topic_0080 | denotes | sequencing |
| T7 | 634-639 | http://edamontology.org/topic_3678 | denotes | study |
| T8 | 706-714 | http://edamontology.org/topic_3168 | denotes | sequence |
| T9 | 706-714 | http://edamontology.org/topic_0080 | denotes | sequence |
| T10 | 706-723 | http://edamontology.org/topic_0080 | denotes | sequence analysis |
| T11 | 929-946 | http://edamontology.org/topic_0134 | denotes | mass spectrometry |
| T12 | 929-946 | http://edamontology.org/topic_3520 | denotes | mass spectrometry |
| T13 | 1364-1372 | http://edamontology.org/topic_3168 | denotes | sequence |
| T14 | 1364-1372 | http://edamontology.org/topic_0080 | denotes | sequence |
| T15 | 1471-1479 | http://edamontology.org/topic_3168 | denotes | sequence |
| T16 | 1471-1479 | http://edamontology.org/topic_0080 | denotes | sequence |
| T17 | 1693-1703 | http://edamontology.org/topic_3168 | denotes | sequencing |
| T18 | 1693-1703 | http://edamontology.org/topic_0080 | denotes | sequencing |
| T19 | 1816-1826 | http://edamontology.org/topic_3168 | denotes | sequencing |
| T20 | 1816-1826 | http://edamontology.org/topic_0080 | denotes | sequencing |
EDAM-DFO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 6-16 | http://edamontology.org/data_2044 | denotes | sequencing |
| T2 | 6-16 | http://edamontology.org/operation_3218 | denotes | sequencing |
| T3 | 139-147 | http://edamontology.org/data_1756 | denotes | residues |
| T4 | 290-299 | http://edamontology.org/operation_3429 | denotes | generated |
| T5 | 301-313 | http://edamontology.org/data_0883 | denotes | structurally |
| T6 | 453-463 | http://edamontology.org/operation_3218 | denotes | sequencing |
| T7 | 453-463 | http://edamontology.org/data_2044 | denotes | sequencing |
| T8 | 490-499 | http://edamontology.org/operation_3429 | denotes | generated |
| T9 | 607-616 | http://edamontology.org/operation_2423 | denotes | detection |
| T10 | 658-667 | http://edamontology.org/operation_2428 | denotes | validated |
| T11 | 706-714 | http://edamontology.org/operation_3218 | denotes | sequence |
| T12 | 706-714 | http://edamontology.org/data_2044 | denotes | sequence |
| T13 | 706-723 | http://edamontology.org/operation_0258 | denotes | sequence analysis |
| T14 | 706-723 | http://edamontology.org/operation_2403 | denotes | sequence analysis |
| T15 | 706-723 | http://edamontology.org/operation_3197 | denotes | sequence analysis |
| T16 | 706-723 | http://edamontology.org/operation_3229 | denotes | sequence analysis |
| T17 | 706-723 | http://edamontology.org/operation_2404 | denotes | sequence analysis |
| T18 | 706-723 | http://edamontology.org/operation_2408 | denotes | sequence analysis |
| T19 | 715-723 | http://edamontology.org/operation_2945 | denotes | analysis |
| T20 | 795-797 | http://edamontology.org/format_1997 | denotes | pH |
| T21 | 863-867 | http://edamontology.org/format_1996 | denotes | pair |
| T22 | 877-882 | http://edamontology.org/operation_3454 | denotes | phase |
| T23 | 877-882 | http://edamontology.org/data_2336 | denotes | phase |
| T24 | 929-946 | http://edamontology.org/data_2536 | denotes | mass spectrometry |
| T25 | 929-946 | http://edamontology.org/data_3147 | denotes | mass spectrometry |
| T26 | 1016-1024 | http://edamontology.org/operation_3435 | denotes | normally |
| T27 | 1043-1052 | http://edamontology.org/operation_2423 | denotes | detection |
| T28 | 1164-1170 | http://edamontology.org/operation_2423 | denotes | detect |
| T29 | 1243-1251 | http://edamontology.org/operation_2945 | denotes | analysis |
| T30 | 1268-1276 | http://edamontology.org/data_1756 | denotes | residues |
| T31 | 1325-1335 | http://edamontology.org/data_0883 | denotes | structural |
| T32 | 1364-1372 | http://edamontology.org/data_2044 | denotes | sequence |
| T33 | 1364-1372 | http://edamontology.org/operation_3218 | denotes | sequence |
| T34 | 1471-1479 | http://edamontology.org/data_2044 | denotes | sequence |
| T35 | 1471-1479 | http://edamontology.org/operation_3218 | denotes | sequence |
| T36 | 1504-1513 | http://edamontology.org/operation_3429 | denotes | generated |
| T37 | 1583-1591 | http://edamontology.org/data_1756 | denotes | residues |
| T38 | 1693-1703 | http://edamontology.org/data_2044 | denotes | sequencing |
| T39 | 1693-1703 | http://edamontology.org/operation_3218 | denotes | sequencing |
| T40 | 1816-1826 | http://edamontology.org/operation_3218 | denotes | sequencing |
| T41 | 1816-1826 | http://edamontology.org/data_2044 | denotes | sequencing |
| T42 | 1841-1849 | http://edamontology.org/data_1756 | denotes | residues |
| T43 | 1868-1870 | http://edamontology.org/format_1997 | denotes | pH |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 46-53 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T2 | 339-346 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
| T3 | 743-750 | http://rdf.glycoinfo.org/glycan/G54161DR | denotes | heparin |
GlycoBiology-Epitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-GlycoEpitope-B_T1 | 54-69 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| PD-GlycoEpitope-B_T2 | 151-166 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-87 | Sentence | denotes | A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides. |
| T2 | 88-227 | Sentence | denotes | The rare N-unsubstituted glucosamine (GlcNH(3)(+)) residues in heparan sulfate (HS) have important biological and pathophysiological roles. |
| T3 | 228-439 | Sentence | denotes | Because of their low natural abundance, the use of chemically generated, structurally defined, N-unsubstituted heparin/HS oligosaccharides can greatly contribute to the investigation of their natural role in HS. |
| T4 | 440-625 | Sentence | denotes | However, the sequencing of mixtures of chemically generated oligosaccharides presents major challenges due to the difficulties in separating isomers and the available detection methods. |
| T5 | 626-771 | Sentence | denotes | In this study, we developed and validated a simple and sensitive method for the sequence analysis of N-unsubstituted heparin/HS oligosaccharides. |
| T6 | 772-966 | Sentence | denotes | This protocol involves pH 4 nitrous acid (HNO(2)) degradation, size-exclusion HPLC and ion-pair reversed-phase liquid chromatography-ion trap/time-of-flight mass spectrometry (IPRP-LC-ITTOF MS). |
| T7 | 967-1277 | Sentence | denotes | We unexpectedly found that absorbance at 232 nm (normally used for specific detection of C4-C5 unsaturated oligosaccharides) was, in most cases, still sufficiently sensitive to also simultaneously detect saturated oligosaccharides during HPLC, thus simplifying the positional analysis of GlcNH(3)(+)) residues. |
| T8 | 1278-1419 | Sentence | denotes | The IPRP-LC-ITTOF MS system can supply further structural information leading to full sequence determination of the original oligosaccharide. |
| T9 | 1420-1649 | Sentence | denotes | This new methodology has been used to separate and sequence a variety of chemically generated, N-unsubstituted dp6 species containing between 1 and 3 GlcNH(3)(+)) residues per oligosaccharide in different positional combinations. |
| T10 | 1650-1891 | Sentence | denotes | This strategy offers possibilities for the sequencing of natural N-unsubstituted oligosaccharides from HS and should also be applicable, with minor modification, for sequencing at N-sulfated residues using alternative pH 1.5 HNO(2) scission. |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 54-69 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T2 | 151-166 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T3 | 168-170 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
| T4 | 347-349 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
| T5 | 436-438 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
| T6 | 751-753 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
| T7 | 1753-1755 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |